IL-13 is released from human primary myotubes in vitro and has been demonstrated to have an “insulin-like” effect on glucose metabolism in human muscle by increasing glucose uptake, glycogen synthesis, and glucose oxidation in normal and T2D primary myotubes (15). The gene discussed is INS; the disease is type 2 diabetes mellitus.